Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
John F. Forbes
Based on 53 articles published since 2009
(Why 53 articles?)
||||
Expertise Level
The expertise of John F. Forbes ranks in the
  • Top 0.11%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 53 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Forbes, J   ·   Forbes, John F   ·   Forbes, J F   ·   Forbes, John
Work Locations
Details
Most likely:    Calvary Mater Newcastle Hospital      
2018
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Leeds Institute of Health Science, University of Leeds, Leeds, UK. · Division of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Surgical Oncology, Calvary Mater Newcastle Hospital, Newcastle, Australia. · Pubmed 29126161
2017
  • Samuel George Smith, Leeds Institute of Health Science, University of Leeds, Leeds · Samuel George Smith, Ivana Sestak, and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London · Anthony Howell, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom · and John Forbes, Calvary Mater Newcastle Hospital, Newcastle, Australia. · Pubmed 28661758
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
2016
  • Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Breast Cancer Network Australia, Newcastle, Vic, Australia. · Monash University, Newcastle, Vic, Australia. · Pubmed 26556210
2015
  • Centre for Information Based Medicine, Hunter Medical Research Institute, NSW, 2305, Australia. · Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, 2308, Australia. · Dept. of Surgical Oncology, Calvary Mater Newcastle Hospital; Australian New Zealand Breast Cancer Trials Group; and School of Medicine and Public Health, University of Newcastle, NSW, 2308, Australia. · Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, 2305, Australia. · Pubmed 26537449
2014
  • Cancer Care Services, Royal Brisbane and Women's Hospital, Butterfield St, Herston, Brisbane, QLD 4029, Australia; University of Queensland, Brisbane, QLD, Australia. Electronic address: · The Mater Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand. · Ballarat Oncology and Haematology Service, Ballarat, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, VIC, Australia. · University of Newcastle, Newcastle, NSW, Australia; Box Hill Hospital, Box Hill, VIC, Australia; Maroondah Breast Clinic, Maroondah Hospital, Ringwood East, VIC, Australia; Monash University, VIC, Australia. · Tweed Hospital, Tweed Heads, NSW, Australia; Griffith University- Gold Coast, Southport, QLD, Australia. · National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia. · Westmead Cancer Care Centre, Westmead Hospital, University of Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia; Department of Surgical Oncology, Calvary Mater Newcastle, Newcastle, NSW, Australia. · Pubmed 24393617
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Australian New Zealand Breast Cancer Trials Group, Calvary Mater Newcastle, University of Newcastle, Waratah, NSW, Australia. · Academic Department of Biochemistry, The Royal Marsden NHS Trust, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · University of Western Australia, Crawley, WA, Australia. · Breast Unit, The Royal Marsden NHS Trust, London, UK. · Department of Surgery, University of Wales College of Medicine, Cardiff, UK. · German Breast Group, Neu-Isenburg, Germany; University Women's Hospital, Frankfurt, Germany. · Division of Chemoprevention and Genetics, European Institute of Oncology, Milan, Italy. · Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · Pubmed 24333009
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.) · SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia · International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.) · National Institute of Oncology, Budapest, Hungary (E.H.) · Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.) · Fox Chase Cancer Center, Philadelphia (L.J.G.) · Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru · Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston · Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas · University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California · National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.) · M.D. Anderson Cancer Center, Houston (G.N.H.) · and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · Guy's and St Thomas Hospital, London, UK. · The University of Tampere, Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · University of Newcastle, Calvary Mater Hospital, Australia New Zealand Breast Cancer Trials Group Newcastle, Australia. · Pubmed 25497694
Probable:    University of Newcastle Australia      
2017
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
2016
  • Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia Patricia Ritchie Centre for Cancer Care and Research, North Sydney. · Ballarat Oncology and Haematology, Wendouree. · Department of Surgery, Royal Adelaide Hospital, Adelaide. · Department of Medical Oncology, Royal Perth Hospital, Perth. · School of Surgery, University of Western Australia, Crawley. · Southern Highlands Cancer Centre, Bowral. · Department of Surgery, St John of God Hospital, Bunbury, Australia. · Breast Care Centre, Waikato Hospital, Hamilton, New Zealand. · Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville. · Australia and New Zealand Breast Cancer Trials Group, Waratah National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Pubmed 26861603
  • Francesco Spagnolo, Ivana Sestak, and Jack Cuzick, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London · Anthony Howell, Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, United Kingdom · and John F. Forbes, Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia. · Pubmed 26598748
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
  • Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Waratah, NSW, Australia. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · South Manchester University Hospital, Manchester, UK. · Centre François Baclesse, Caen, France. · German Breast Group, Frankfurt, Germany. · Interdisziplinares Onkologisches Zentrum, Munich, Germany. · Department of Oncology, KU Leuven, University of Leuven, Leuven, Belgium. · Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · Department of Oncology and Metabolism, Weston Park Hospital, Sheffield, UK. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Department of Histopathology University of Nottingham, Nottingham, UK. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Pubmed 26686313
  • Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Breast Cancer Network Australia, Newcastle, Vic, Australia. · Monash University, Newcastle, Vic, Australia. · Pubmed 26556210
2015
  • Centre for Information Based Medicine, Hunter Medical Research Institute, NSW, 2305, Australia. · Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, 2308, Australia. · Dept. of Surgical Oncology, Calvary Mater Newcastle Hospital; Australian New Zealand Breast Cancer Trials Group; and School of Medicine and Public Health, University of Newcastle, NSW, 2308, Australia. · Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, 2305, Australia. · Pubmed 26537449
  • Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. · Department of Pathology, Western Infirmary, Glasgow, United Kingdom. · Christie Hospital, Manchester Breast Centre and Breakthrough Breast Cancer Research Unit, Manchester, United Kingdom. · Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26078431
  • School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. · Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia; School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia. · Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. · Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA. · School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. Electronic address: · Pubmed 26009480
  • 1] Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] St Vincent's Clinical School, University of NSW, Sydney, New South Wales 2010, Australia. · Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia. · 1] Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] School of Mathematics and Statistics, University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] Swiss Institute of Bioinformatics and Institute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales 2308, Australia. · School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia. · 1] School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia [2] Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Pathology Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia. · Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland 4072, Australia. · 1] School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia [2] Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland 4072, Australia. · School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales 2305, Australia. · 1] School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales 2308, Australia [2] Division of Molecular Medicine, Hunter Area Pathology Service and the Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales 2305, Australia. · 1] Pathology Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia [2] Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland 4072, Australia. · Pubmed 25641231
2014
  • Cancer Care Services, Royal Brisbane and Women's Hospital, Butterfield St, Herston, Brisbane, QLD 4029, Australia; University of Queensland, Brisbane, QLD, Australia. Electronic address: · The Mater Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand. · Ballarat Oncology and Haematology Service, Ballarat, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, VIC, Australia. · University of Newcastle, Newcastle, NSW, Australia; Box Hill Hospital, Box Hill, VIC, Australia; Maroondah Breast Clinic, Maroondah Hospital, Ringwood East, VIC, Australia; Monash University, VIC, Australia. · Tweed Hospital, Tweed Heads, NSW, Australia; Griffith University- Gold Coast, Southport, QLD, Australia. · National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia. · Westmead Cancer Care Centre, Westmead Hospital, University of Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia; Department of Surgical Oncology, Calvary Mater Newcastle, Newcastle, NSW, Australia. · Pubmed 24393617
  • Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), The University of Sydney, Sydney 2006, Australia. · Australia and New Zealand Breast Cancer Trials Group, Australia University of Newcastle, Newcastle 2306, Australia. · 1] Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), The University of Sydney, Sydney 2006, Australia [2] Australia and New Zealand Breast Cancer Trials Group, Australia University of Newcastle, Newcastle 2306, Australia [3] Pam McLean Centre, The University of Sydney, Sydney 2006, Australia. · Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary College, University of London, London E1 4NS, UK. · Pubmed 24892447
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Australian New Zealand Breast Cancer Trials Group, Calvary Mater Newcastle, University of Newcastle, Waratah, NSW, Australia. · Academic Department of Biochemistry, The Royal Marsden NHS Trust, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · University of Western Australia, Crawley, WA, Australia. · Breast Unit, The Royal Marsden NHS Trust, London, UK. · Department of Surgery, University of Wales College of Medicine, Cardiff, UK. · German Breast Group, Neu-Isenburg, Germany; University Women's Hospital, Frankfurt, Germany. · Division of Chemoprevention and Genetics, European Institute of Oncology, Milan, Italy. · Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · Pubmed 24333009
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2015
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · Guy's and St Thomas Hospital, London, UK. · The University of Tampere, Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · University of Newcastle, Calvary Mater Hospital, Australia New Zealand Breast Cancer Trials Group Newcastle, Australia. · Pubmed 25497694
2014
  • Centre for Information-Based Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia. · Pubmed 24725360
  • Centre for Information-Based Medicine, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. · Pubmed 24479446
Probable:    Miscellaneous institutions in Newcastle, AU      
2016
  • Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Breast Cancer Network Australia, Newcastle, Vic, Australia. · Monash University, Newcastle, Vic, Australia. · Pubmed 26556210
  • Australia and New Zealand Breast Cancer Trials Group, Newcastle, New South Wales, Australia. · Breast Cancer Network Australia, Camberwell, Victoria, Australia. · Pubmed 26530428
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 53 total) written by John F. Forbes about Breast Neoplasms:

  • Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II. 2018
  • Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I). 2017
  • HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. 2017
  • Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. 2016
  • Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial. 2016
  • Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial. 2016
  • Adjuvant ovarian function suppression and cognitive function in women with breast cancer. 2016
  • Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. 2016
  • Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. 2016
  • Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options. 2016
Show List of Full Article Records
Google Searches

Learn more about John F. Forbes using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Calvary Mater Newcastle Hospital
University of Newcastle Australia
Miscellaneous institutions in Newcastle, AU
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Calvary Mater Newcastle Hospital
2018
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Leeds Institute of Health Science, University of Leeds, Leeds, UK. · Division of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Surgical Oncology, Calvary Mater Newcastle Hospital, Newcastle, Australia. · Pubmed 29126161
2017
  • Samuel George Smith, Leeds Institute of Health Science, University of Leeds, Leeds · Samuel George Smith, Ivana Sestak, and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London · Anthony Howell, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom · and John Forbes, Calvary Mater Newcastle Hospital, Newcastle, Australia. · Pubmed 28661758
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
2016
  • Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Breast Cancer Network Australia, Newcastle, Vic, Australia. · Monash University, Newcastle, Vic, Australia. · Pubmed 26556210
2015
  • Centre for Information Based Medicine, Hunter Medical Research Institute, NSW, 2305, Australia. · Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, 2308, Australia. · Dept. of Surgical Oncology, Calvary Mater Newcastle Hospital; Australian New Zealand Breast Cancer Trials Group; and School of Medicine and Public Health, University of Newcastle, NSW, 2308, Australia. · Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, 2305, Australia. · Pubmed 26537449
2014
  • Cancer Care Services, Royal Brisbane and Women's Hospital, Butterfield St, Herston, Brisbane, QLD 4029, Australia; University of Queensland, Brisbane, QLD, Australia. Electronic address: · The Mater Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand. · Ballarat Oncology and Haematology Service, Ballarat, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, VIC, Australia. · University of Newcastle, Newcastle, NSW, Australia; Box Hill Hospital, Box Hill, VIC, Australia; Maroondah Breast Clinic, Maroondah Hospital, Ringwood East, VIC, Australia; Monash University, VIC, Australia. · Tweed Hospital, Tweed Heads, NSW, Australia; Griffith University- Gold Coast, Southport, QLD, Australia. · National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia. · Westmead Cancer Care Centre, Westmead Hospital, University of Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia; Department of Surgical Oncology, Calvary Mater Newcastle, Newcastle, NSW, Australia. · Pubmed 24393617
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Australian New Zealand Breast Cancer Trials Group, Calvary Mater Newcastle, University of Newcastle, Waratah, NSW, Australia. · Academic Department of Biochemistry, The Royal Marsden NHS Trust, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · University of Western Australia, Crawley, WA, Australia. · Breast Unit, The Royal Marsden NHS Trust, London, UK. · Department of Surgery, University of Wales College of Medicine, Cardiff, UK. · German Breast Group, Neu-Isenburg, Germany; University Women's Hospital, Frankfurt, Germany. · Division of Chemoprevention and Genetics, European Institute of Oncology, Milan, Italy. · Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · Pubmed 24333009
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.) · SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia · International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.) · National Institute of Oncology, Budapest, Hungary (E.H.) · Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.) · Fox Chase Cancer Center, Philadelphia (L.J.G.) · Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru · Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston · Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas · University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California · National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.) · M.D. Anderson Cancer Center, Houston (G.N.H.) · and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · Guy's and St Thomas Hospital, London, UK. · The University of Tampere, Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · University of Newcastle, Calvary Mater Hospital, Australia New Zealand Breast Cancer Trials Group Newcastle, Australia. · Pubmed 25497694
University of Newcastle Australia
2017
  • Transformative Pathology, Ontario Institute for Cancer Research (OICR), MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada; University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Department of Pathology, Elizabeth University Hospital, 1345 Govan Road, Govan, Glasgow G51 4TF, UK. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Breast Center, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research SAKK, CH-9007 St. Gallen, Switzerland. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, Rotterdam 3008 AE, The Netherlands. Electronic address: · Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Division of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address: · Leicester Clinical Trials Unit, University of Leicester, Leicester LE5 4PW, UK. Electronic address: · Surgical Oncology, University of Newcastle, Calvary Mater Newcastle Hospital, Locked Bag 7, HRMC, Newcastle, NSW 2310, Australia. Electronic address: · Department of Pathology, European Institute of Oncology and University of Milan, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: · Academic Department of Biochemistry, Royal Marsden Hospital, and Endocrinology, Breakthrough Breast Cancer Centre, Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: · Pubmed 28494403
2016
  • Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia Patricia Ritchie Centre for Cancer Care and Research, North Sydney. · Ballarat Oncology and Haematology, Wendouree. · Department of Surgery, Royal Adelaide Hospital, Adelaide. · Department of Medical Oncology, Royal Perth Hospital, Perth. · School of Surgery, University of Western Australia, Crawley. · Southern Highlands Cancer Centre, Bowral. · Department of Surgery, St John of God Hospital, Bunbury, Australia. · Breast Care Centre, Waikato Hospital, Hamilton, New Zealand. · Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville. · Australia and New Zealand Breast Cancer Trials Group, Waratah National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Pubmed 26861603
  • Francesco Spagnolo, Ivana Sestak, and Jack Cuzick, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London · Anthony Howell, Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, United Kingdom · and John F. Forbes, Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia. · Pubmed 26598748
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
  • Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Waratah, NSW, Australia. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · South Manchester University Hospital, Manchester, UK. · Centre François Baclesse, Caen, France. · German Breast Group, Frankfurt, Germany. · Interdisziplinares Onkologisches Zentrum, Munich, Germany. · Department of Oncology, KU Leuven, University of Leuven, Leuven, Belgium. · Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · Department of Oncology and Metabolism, Weston Park Hospital, Sheffield, UK. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Department of Histopathology University of Nottingham, Nottingham, UK. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Pubmed 26686313
  • Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Breast Cancer Network Australia, Newcastle, Vic, Australia. · Monash University, Newcastle, Vic, Australia. · Pubmed 26556210
2015
  • Centre for Information Based Medicine, Hunter Medical Research Institute, NSW, 2305, Australia. · Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, 2308, Australia. · Dept. of Surgical Oncology, Calvary Mater Newcastle Hospital; Australian New Zealand Breast Cancer Trials Group; and School of Medicine and Public Health, University of Newcastle, NSW, 2308, Australia. · Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, 2305, Australia. · Pubmed 26537449
  • Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. · Department of Pathology, Western Infirmary, Glasgow, United Kingdom. · Christie Hospital, Manchester Breast Centre and Breakthrough Breast Cancer Research Unit, Manchester, United Kingdom. · Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26078431
  • School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. · Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia; School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia. · Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. · Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA. · School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. Electronic address: · Pubmed 26009480
  • 1] Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] St Vincent's Clinical School, University of NSW, Sydney, New South Wales 2010, Australia. · Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia. · 1] Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] School of Mathematics and Statistics, University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Epigenetics Group, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] Swiss Institute of Bioinformatics and Institute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales 2308, Australia. · School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia. · 1] School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia [2] Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Pathology Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia. · Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland 4072, Australia. · 1] School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia [2] Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland 4072, Australia. · School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales 2305, Australia. · 1] School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales 2308, Australia [2] Division of Molecular Medicine, Hunter Area Pathology Service and the Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales 2305, Australia. · 1] Pathology Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia [2] Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland 4072, Australia. · Pubmed 25641231
2014
  • Cancer Care Services, Royal Brisbane and Women's Hospital, Butterfield St, Herston, Brisbane, QLD 4029, Australia; University of Queensland, Brisbane, QLD, Australia. Electronic address: · The Mater Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand. · Ballarat Oncology and Haematology Service, Ballarat, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, VIC, Australia. · University of Newcastle, Newcastle, NSW, Australia; Box Hill Hospital, Box Hill, VIC, Australia; Maroondah Breast Clinic, Maroondah Hospital, Ringwood East, VIC, Australia; Monash University, VIC, Australia. · Tweed Hospital, Tweed Heads, NSW, Australia; Griffith University- Gold Coast, Southport, QLD, Australia. · National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia. · Westmead Cancer Care Centre, Westmead Hospital, University of Sydney, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia; Department of Surgical Oncology, Calvary Mater Newcastle, Newcastle, NSW, Australia. · Pubmed 24393617
  • Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), The University of Sydney, Sydney 2006, Australia. · Australia and New Zealand Breast Cancer Trials Group, Australia University of Newcastle, Newcastle 2306, Australia. · 1] Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), The University of Sydney, Sydney 2006, Australia [2] Australia and New Zealand Breast Cancer Trials Group, Australia University of Newcastle, Newcastle 2306, Australia [3] Pam McLean Centre, The University of Sydney, Sydney 2006, Australia. · Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary College, University of London, London E1 4NS, UK. · Pubmed 24892447
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Australian New Zealand Breast Cancer Trials Group, Calvary Mater Newcastle, University of Newcastle, Waratah, NSW, Australia. · Academic Department of Biochemistry, The Royal Marsden NHS Trust, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · University of Western Australia, Crawley, WA, Australia. · Breast Unit, The Royal Marsden NHS Trust, London, UK. · Department of Surgery, University of Wales College of Medicine, Cardiff, UK. · German Breast Group, Neu-Isenburg, Germany; University Women's Hospital, Frankfurt, Germany. · Division of Chemoprevention and Genetics, European Institute of Oncology, Milan, Italy. · Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · Pubmed 24333009
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2015
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · Guy's and St Thomas Hospital, London, UK. · The University of Tampere, Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · University of Newcastle, Calvary Mater Hospital, Australia New Zealand Breast Cancer Trials Group Newcastle, Australia. · Pubmed 25497694
2014
  • Centre for Information-Based Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia. · Pubmed 24725360
  • Centre for Information-Based Medicine, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia. · Pubmed 24479446
Miscellaneous institutions in Newcastle, AU
2016
  • Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Calvary Mater Newcastle, Newcastle, NSW, Australia. · University of Newcastle, Newcastle, NSW, Australia. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia. · Breast Cancer Network Australia, Newcastle, Vic, Australia. · Monash University, Newcastle, Vic, Australia. · Pubmed 26556210
  • Australia and New Zealand Breast Cancer Trials Group, Newcastle, New South Wales, Australia. · Breast Cancer Network Australia, Camberwell, Victoria, Australia. · Pubmed 26530428
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
Mater Hospital
2016
  • Francesco Spagnolo, Ivana Sestak, and Jack Cuzick, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London · Anthony Howell, Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, United Kingdom · and John F. Forbes, Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia. · Pubmed 26598748
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
2015
  • Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom. · Royal Marsden Hospital and Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom. · Department of Pathology, Western Infirmary, Glasgow, United Kingdom. · Christie Hospital, Manchester Breast Centre and Breakthrough Breast Cancer Research Unit, Manchester, United Kingdom. · Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26078431
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.) · SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia · International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.) · National Institute of Oncology, Budapest, Hungary (E.H.) · Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.) · Fox Chase Cancer Center, Philadelphia (L.J.G.) · Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru · Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston · Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas · University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California · National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.) · M.D. Anderson Cancer Center, Houston (G.N.H.) · and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · Guy's and St Thomas Hospital, London, UK. · The University of Tampere, Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · University of Newcastle, Calvary Mater Hospital, Australia New Zealand Breast Cancer Trials Group Newcastle, Australia. · Pubmed 25497694
Sjaellands Universitetshospital
2016
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
2015
  • Centre for Information Based Medicine, Hunter Medical Research Institute, NSW, 2305, Australia. · Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, 2308, Australia. · Dept. of Surgical Oncology, Calvary Mater Newcastle Hospital; Australian New Zealand Breast Cancer Trials Group; and School of Medicine and Public Health, University of Newcastle, NSW, 2308, Australia. · Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, 2305, Australia. · Pubmed 26537449
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.) · SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia · International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.) · National Institute of Oncology, Budapest, Hungary (E.H.) · Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.) · Fox Chase Cancer Center, Philadelphia (L.J.G.) · Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru · Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston · Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas · University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California · National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.) · M.D. Anderson Cancer Center, Houston (G.N.H.) · and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK. · Breast Care Centre, Southmead Hospital, Bristol, UK. · Guy's and St Thomas Hospital, London, UK. · The University of Tampere, Pirkanmaa Cancer Society, Tampere, Finland. · Genesis Breast Cancer Prevention Centre, Manchester, UK. · University of Newcastle, Calvary Mater Hospital, Australia New Zealand Breast Cancer Trials Group Newcastle, Australia. · Pubmed 25497694
Unspecified
2016
  • Jacquie H. Chirgwin and John F. Forbes, University of Newcastle · John F. Forbes, Calvary Mater Newcastle, Newcastle · Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales · Jacquie H. Chirgwin, Box Hill Hospital · Jacquie H. Chirgwin, Maroondah Hospital · Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia · Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard Medical School, Boston, MA · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergonié, Bordeaux, France · Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy · Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom · Manuela Rabaglio, Inselspital, Bern · Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland · Patrick Neven, University of Leuven · Patrick Neven, University Hospitals Leuven, Leuven, Belgium · István Láng, National Institute of Oncology, Budapest, Hungary. · Pubmed 27217455
McMaster University
2015
  • Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. · Centre for Probe Development and Commercialization (CPDC), McMaster University, Hamilton, Ontario, Canada. · Centre for Probe Development and Commercialization (CPDC), McMaster University, Hamilton, Ontario, Canada; Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario, Canada. Electronic address: · Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 25542669
University of Limerick
2015
  • Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Centre for Research on Health and Social Care Management, CERGAS, Bocconi University. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK. · Lothian Analytical Services, NHS Lothian, Edinburgh, UK. · NHS Lothian, Edinburgh, UK. · Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. · Centre for Health and Social Economics (CHESS), National Institute for Health and Welfare, Helsinki, Finland. · Medical Management Centre, Karolinska Institutet, Stockholm, Sweden. · Health Research Institute, University of Limerick, Limerick, Ireland. · Pubmed 26633866
23 Other Locations Show
Yearly article counts 0128106471410
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.